Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics announces publication of Annual Report 2018 and Extraordinary General Meeting on 23 May 2019

Regulated information Gosselies, Belgium, 25 April 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in...
April 23, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 23 May 2019 have been made available

Regulated information Gosselies, Belgium, 23 April 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in...
April 23, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 23 mai 2019

Information réglementée Gosselies, Belgique, le 23 avril 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à...
March 28, 2019 02:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions

Information réglementée Gosselies, Belgique, le 28 mars 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à...
March 28, 2019 02:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: Information on the total number of voting rights and shares

Regulated information Gosselies, Belgium, 28 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs...
March 18, 2019 02:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics to present data at Herbert Fleisch / IFMRS Workshop

Press release Gosselies, Belgium, 18 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in...
March 12, 2019 03:17 ET | Source: Bone Therapeutics SA

Bone Therapeutics appoints Olivier Godeaux as Chief Medical Officer and Benoit Moreaux as Chief Scientific and Technology Officer

Press Release Gosselies, Belgium, 12 March 2019, 8am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in...
March 12, 2019 03:17 ET | Source: Bone Therapeutics SA

Bone Therapeutics annonce les nominationsd’Olivier Godeaux au poste de Chief Medical Officer et de Benoit Moreaux au poste de Chief Scientific and Technology Officer

Communiqué de presse Gosselies, Belgique, le 12 mars 2019, 8h00 CET - BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de thérapie cellulaire osseuse qui...
March 05, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: Information on the total number of voting rights and shares

Regulated information Gosselies, Belgium, 5 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in...
March 05, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions

Information réglementée Gosselies, Belgique, le 5 mars 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à...